正海生物
(300653)
| 流通市值：30.28亿 | | | 总市值：30.28亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 81,028,747.68 | 364,138,509.83 | 275,718,204.42 | 187,841,101.88 |
| 营业收入 | 81,028,747.68 | 364,138,509.83 | 275,718,204.42 | 187,841,101.88 |
| 二、营业总成本 | 67,086,219.15 | 290,742,077.78 | 212,425,741.37 | 143,865,571.16 |
| 营业成本 | 14,060,006.1 | 51,426,459.6 | 41,277,017.2 | 30,213,509.82 |
| 税金及附加 | 1,818,193.11 | 5,156,169.61 | 3,354,638.59 | 1,526,749.77 |
| 销售费用 | 32,266,207.36 | 142,344,653.3 | 104,892,955.22 | 71,177,884.11 |
| 管理费用 | 8,636,027.56 | 34,838,163.98 | 25,370,586.05 | 15,977,056.07 |
| 研发费用 | 10,351,566.19 | 57,326,389.63 | 37,792,293.4 | 25,141,166.78 |
| 财务费用 | -45,781.17 | -349,758.34 | -261,749.09 | -170,795.39 |
| 其中:利息费用 | - | 11,554.07 | 11,554.07 | 11,554.07 |
| 其中:利息收入 | 50,841.88 | 384,591.99 | 322,927.41 | 231,720.09 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,691,700.04 | 5,108,162.71 | 4,945,809.95 | 6,826,468.71 |
| 加:投资收益 | 363,285.32 | 8,436,117.26 | 4,099,940.62 | 151,184.09 |
| 信用减值损失(新) | -83,529.07 | -266,887.61 | -278,940.73 | -252,366.32 |
| 其他收益 | 271,875.56 | 2,553,053.94 | 1,122,340.39 | 703,374.97 |
| 四、营业利润 | 17,185,860.38 | 89,226,878.35 | 73,181,613.28 | 51,404,192.17 |
| 加:营业外收入 | 67,775.27 | 71,304.81 | 63,124.8 | 35,049.28 |
| 减:营业外支出 | 52,789.45 | 1,172,532.4 | 62,234.72 | 26,069.2 |
| 五、利润总额 | 17,200,846.2 | 88,125,650.76 | 73,182,503.36 | 51,413,172.25 |
| 减:所得税费用 | 2,451,577.68 | 5,715,519.06 | 5,780,307.52 | 4,927,439.59 |
| 六、净利润 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 | 46,485,732.66 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 | 46,485,732.66 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 | 46,485,732.66 |
| 扣除非经常损益后的净利润 | 12,008,081.13 | 69,663,441.33 | 59,181,608.69 | 40,280,695.94 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.46 | 0.37 | 0.26 |
| (二)稀释每股收益 | 0.08 | 0.46 | 0.37 | 0.26 |
| 九、综合收益总额 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 | 46,485,732.66 |
| 归属于母公司股东的综合收益总额 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 | 46,485,732.66 |
| 公告日期 | 2026-04-18 | 2026-03-31 | 2025-10-25 | 2025-08-05 |
| 审计意见(境内) | | 标准无保留意见 | | |